IDE Medicare reimbursement categorization for ongoing studies to be completed by Oct. 6 -- FDA.
This article was originally published in The Gray Sheet
Executive Summary
IDE MEDICARE REIMBURSEMENT: RE-EVALUATION REQUESTS REQUIRE IDE SUPPLEMENTS, FDA says in a Sept. 15 "blue book" memo outlining the agency's responsibilities for implementing an interagency agreement with the Health Care Financing Administration for Medicare reimbursement of investigational devices. For devices initially designated "Category A experimental ," which are not eligible for Medicare coverage, sponsors are directed to submit a written request for re-evaluation in the form of an investigational device exemption supplement to the appropriate division within FDA's Office of Device Evaluation.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.